Home
About the program
Awards
Essential Info
Submit a Proposal
Contact Us

Co-Chair - Dr Jennifer Arnold

Co-Chair of the Grants Review and Awards Committee
Dr Jennifer Arnold


Co-Chair - Professor Quan Nguyen

Co-Chair of the Grants Review and Awards Committee
Professor Quan Nguyen

View all members of the Grants Review and Awards Committee

The Global Ophthalmology Awards Program (GOAP) is an initiative instituted by Bayer that supports research and training in retinal ophthalmology with the aim of advancing the scientific understanding and clinical management of ophthalmic disorders. Through research and training grants the program seeks to provide opportunities for ophthalmology healthcare professionals that will ultimately lead to improved treatment and management for the world’s ophthalmology patients.

Learn more about the program

Want to apply for the Global Ophthalmology Awards Program?
IMPORTANT DATES:

March 30, 2018
Letter of Intent submission deadline

May 16, 2018
Applicants notified of the decision; Full Proposal forms distributed to successful applicants

June 14, 2018
Full Proposal submission deadline

July 2018
Applicants notified of the decision

September 20, 2018
Annual Ceremony


©2018 Bayer. All rights reserved.
General Conditions of Use | Privacy Statement | Imprint
 

Report Adverse Events
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search MHRA Yellow Card in the Google Play or Apple App Store.
Adverse events should also be reported to Bayer plc.
Tel.: 0118 2063500, Fax.: 0118 2063703, Email: pvuk@bayer.com.

The Global Ophthalmology Awards Program is an international awards program. | This website is intended for UK scientists and healthcare professionals only.
Non UK audience, please visit www.bayer-ophthalmology-awards.com. To access the Bayer website, please visit www.bayer.co.uk.


Date of preparation: May 2018
Job code: UKEYL11170247m

The Global Ophthalmology Awards Program from Bayer is an educational initiative fully funded by Bayer